NSD1 and spondylo-ocular syndrome: The molecular analysis allowed for the identification of 292 patients (281 with clinical suspicion of SoS and 11 with not-specific-overgrowth) with one NSD1 variant out of 1530 patients analyzed, with a detection rate of 19.1% (N = 292/1530).